Stools
PreclinicalBiologic
Stools is one of 45 biologic programs targeting Clostridium Difficile Infection. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
44
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
309 competitors in COVID-19
#DrugCompanyPhaseTrials
1Glucocorticoid
AbbViePreclinical
Statins
SanofiPreclinical
Rayaldee
OOrganon and Co
Preclinical
SARS-COV-2 VACCINE
ModernaPreclinical
Biological Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Aprotinin
BayerPreclinical
Sivelestat Sodium
TThe First Hospital of Jilin University
Preclinical
Antihypertensive Agents
NNational Heart, Lung, and Blood Institute (NHLBI)
Preclinical
Pfizer-COVID-19 Vaccine
ModernaPreclinical
Olokizumab
UCBPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Stools. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- VVersailles Hospital